Kedrion Biopharma, commonly referred to as Kedrion, is a leading global player in the biopharmaceutical industry, headquartered in Italy. Founded in 2001, the company has established a strong presence in major operational regions, including Europe and North America, focusing on the development and production of human plasma-derived therapies. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. What sets Kedrion apart is its commitment to quality and innovation, ensuring that its products meet the highest safety standards. With a robust market position, Kedrion has achieved significant milestones, including expanding its product portfolio and enhancing its global distribution network, solidifying its reputation as a trusted provider in the biopharmaceutical sector.
How does Kedrion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Kedrion's score of 25 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Kedrion S.p.A. reported total carbon emissions of approximately 1,102 kg CO2e, comprising 1,081 kg CO2e from Scope 1 and 21 kg CO2e from Scope 2 emissions. This marked a significant reduction from 2020, where emissions were about 6,600 kg CO2e, with 6,573 kg CO2e from Scope 1 and 27 kg CO2e from Scope 2. The data indicates a trend towards lower emissions, particularly in Scope 1, which saw a decrease of about 5,492 kg CO2e year-on-year. Kedrion has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets through initiatives such as the Science Based Targets initiative (SBTi). The company operates as a current subsidiary of Kedrion Holding Spa, which may influence its climate commitments and reporting practices. Despite the absence of formal reduction targets, Kedrion's emissions data reflects a commitment to improving their carbon footprint. The company continues to monitor and report its emissions, aligning with industry standards for transparency and accountability in climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Scope 1 | 22,062,000 | 00,000,000 | 0,000,000 | 0,000 | 0,000 |
| Scope 2 | - | - | - | 00 | 00 |
| Scope 3 | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Kedrion has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.